Drug intelligence / Profile preview

gentamicin + heparin

Development stage: Unknown
Modality: Small Molecules
Administration: Intracatheter

Overview

A combination of gentamicin (an aminoglycoside antibiotic) and heparin (an anticoagulant) used primarily in antibiotic lock therapy for treating or preventing catheter-related bloodstream infections. This combination has been controversial due to historical concerns about compatibility, but recent research suggests stability under specific concentration parameters.

Targets

Bacterial RibosomeATIII (Antithrombin III)

Beyond the preview

Go deeper on gentamicin + heparin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on gentamicin + heparin.

Explore the full profile